Navigation Links
Device That Targets Brain Cancer Shows Promising Results

Early data for an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields , called Tumor-Treating Fields (TTFields), has found that it more than doubled the median overall survival rates in patients with the most common and aggressive type of malignant brain tumor.

The device, called the Novo-TTF, uses electrical fields to disrupt tumor growth by interfering with cell division of cancerous cells, causing them to stop proliferating and die off instead of dividing and growing.

Healthy brain cells rarely divide and have different electrical properties than cancerous brain cells. This allows the device to target cancer cells without affecting the healthy cells.

The 10 patients who were being treated with the device were suffering from recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.

Researchers found that among the patients treated with the Novo-TTF, the median length of time to disease progression was 26.1 weeks; progression free survival at six months was 50 percent; and median overall survival was 62.2 weeks.

This is more than double the rates reported in historical data approximately 9.5 weeks, 15.3 percent, and 29.3 weeks, respectively.

"The novel mechanism of action of the Novo-TTF relies on the physical properties of the cancer cells, their shape and size, rather than the chemical make-up. We believe that this distinction enables the device to stop local proliferation and metastasis of cancer, which would explain the efficacy observed in these early findings," said Dr. Elion Kirson lead author and Vice President of Research and Development, NovoCure.

"Based on our preliminary research, we believe that there is a high probability that TTFields may prove to be an effective and safe approach to treating a large number of human cancers," Dr Kirson a dded.

This research, which includes the results of cell culture, animal and early phase human trials, appears in the current issue of the Proceedings of the National Academy of Sciences (PNAS).


'"/>




Related medicine news :

1. Injection supports Heart Devices
2. New Heart-Screening Device ,An Accurate Predictor Of Heart Disease
3. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
4. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
5. New Implantable Device That Can Keep The Heart Ticking
6. Making MRIs Safe for Patients With Implantable Heart Devices
7. Researchers Develop Device For Detecting Atherosclerotic Plaques
8. A Cheap Device to Stop Snoring from New Zealand
9. Scientists Concerned Over Increasing Malfunction Of Heart Devices
10. Device For Improving Bone Mass In Osteoporosis
11. Anti-Microbial Coating For Use Over Biomedical Devices Developed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... URise ... its newest mobility device, the StandUp Walker. Made entirely in the USA, the ... last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 benefits ...
(Date:2/9/2016)... MA (PRWEB) , ... February 09, 2016 , ... ... (WCRI) compares the workers’ compensation fee schedule rates and Medicare rates for a ... services covered in the report, Evaluation of the 2015 Fee Schedule Rates ...
(Date:2/9/2016)... Atlanta, GA (PRWEB) , ... February 09, 2016 ... ... partnered with Transformation Solutions, LLC to help enterprises move workloads to the cloud. ... to directly connect to their cloud without traversing the Internet. Transformation Solutions ...
(Date:2/9/2016)... , ... February 09, 2016 ... ... and e-book publishing software, in partnership with Snowfall4pod Digital, creators of the ... comprehensive book publishing, content management, global distribution and print-on-demand network. , AVALANCHE ...
(Date:2/9/2016)... ... February 09, 2016 , ... BioPlus Specialty Pharmacy (BioPlus), ... the ‘Pay It Forward’ program into 2016. BioPlus partners with several non-profit patient ... , “Since our Pay It Forward program began, we are proud to ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Otsuka Pharmaceutical Co., ... that they have entered into a licensing agreement granting ... the U.S. and Puerto Rico . ... topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a new treatment ... --> In a Phase II clinical trial, ...
(Date:2/8/2016)... 2016  Echo Therapeutics, Inc. (Nasdaq: ... on non-invasive continuous glucose monitoring (CGM) and ... it will host a webcast and conference ... 9:00 a.m. Eastern Time to provide a ... advancements in its CGM system, and its ...
(Date:2/8/2016)... -- http://www.researchandmarkets.com/research/fqx6nz/global_skin ) has announced ... Equipment Market 2016-2020" report to their offering. ... announced the addition of the "Global Skin ... offering. --> Research and ... of the "Global Skin Protective Equipment Market ...
Breaking Medicine Technology: